NCT06927414View on ClinicalTrials.gov

Light Diffraction Glasses in Preventing and Controlling Myopia in Adolescents

NAActive, not recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

April 30, 2025

Study Completion Date

June 30, 2025

Conditions
Myopia Progressing
Interventions
DEVICE

Functional lens

Diffractive Optical Element, D.O.E, technology for controlling myopia progression in children and adolescents. and H.A.L.T, highly aspheric lenslet technology) for controlling myopia progression in children and adolescents.

Trial Locations (1)

200050

Shanghai Eye Diseases Prevention &Treatment Center/ Shanghai Eye Hospital, School of Medicine, Tongji University, Shanghai

All Listed Sponsors
lead

Shanghai Eye Disease Prevention and Treatment Center

OTHER

NCT06927414 - Light Diffraction Glasses in Preventing and Controlling Myopia in Adolescents | Biotech Hunter | Biotech Hunter